We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $14.1B
1-Year Est. Return 30.11%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$13.3B
AUM Growth
+$700M
Cap. Flow
+$449M
Cap. Flow %
3.37%
Top 10 Hldgs %
41.95%
Holding
1,618
New
92
Increased
926
Reduced
540
Closed
48

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$25.8M
2
META icon
Meta Platforms (Facebook)
META
+$20.6M
3
MSFT icon
Microsoft
MSFT
+$18.6M
4
NVDA icon
NVIDIA
NVDA
+$15.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.9M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.88M
2
MPC icon
Marathon Petroleum
MPC
+$4.71M
3
K
Kellanova
K
+$3.29M
4
J icon
Jacobs Solutions
J
+$2.43M
5
SNA icon
Snap-on
SNA
+$2.28M

Sector Composition

Rank Sector Weight
1 Technology 38.09%
2 Financials 11.48%
3 Consumer Discretionary 11.15%
4 Communication Services 11.06%
5 Healthcare 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOPN icon
1551
Kopin
KOPN
$704M
$31.9K ﹤0.01%
13,614
+1,192
+10% +$3.44K
CYH icon
1552
Community Health Systems
CYH
$392M
$31.3K ﹤0.01%
10,023
-114
-1% -$383
LAB icon
1553
Standard BioTools
LAB
$343M
$30.2K ﹤0.01%
23,597
+195
+0.8% +$262
CERS icon
1554
Cerus
CERS
$575M
$29.5K ﹤0.01%
14,322
CLNE icon
1555
Clean Energy Fuels
CLNE
$460M
$28.4K ﹤0.01%
13,538
-84
-0.6% -$205
RC
1556
Ready Capital
RC
$267M
$26.4K ﹤0.01%
12,105
-977
-7% -$2.74K
BYND icon
1557
Beyond Meat
BYND
$289M
$24.5K ﹤0.01%
+29,893
New +$41.6K
SVC
1558
Service Properties Trust
SVC
$1.1B
$22.2K ﹤0.01%
2,411
CNDT icon
1559
Conduent
CNDT
$226M
$21.8K ﹤0.01%
11,346
-274
-2% -$600
EGHT icon
1560
8x8 Inc
EGHT
$228M
$20.5K ﹤0.01%
10,392
MVIS icon
1561
Microvision
MVIS
$96.4M
$18.8K ﹤0.01%
22,704
+3,314
+17% +$3.52K
AGL icon
1562
Agilon Health
AGL
$1.67B
$16.7K ﹤0.01%
971
+12
+1% +$233
ALLO icon
1563
Allogene Therapeutics
ALLO
$628M
$16.2K ﹤0.01%
11,805
NFE icon
1564
New Fortress Energy
NFE
$95.7M
$15.5K ﹤0.01%
13,620
+379
+3% +$559
HRTX icon
1565
Heron Therapeutics
HRTX
$86.9M
$15.5K ﹤0.01%
11,893
SLQT icon
1566
SelectQuote
SLQT
$122M
$15.3K ﹤0.01%
10,885
+231
+2% +$386
OLPX
1567
DELISTED
Olaplex Holdings
OLPX
$14.9K ﹤0.01%
11,120
+131
+1% +$156
QSI icon
1568
Quantum-Si Incorporated
QSI
$172M
$13K ﹤0.01%
11,824
-128
-1% -$208
FFAI
1569
Faraday Future Intelligent Electric
FFAI
$26.1M
$11.4K ﹤0.01%
+11,144
New +$13.8K
HUMA icon
1570
Humacyte
HUMA
$172M
$11.1K ﹤0.01%
+11,550
New +$16.4K
ACLX
1571
DELISTED
Arcellx
ACLX
-2,694
Closed -$221K
AKRO
1572
DELISTED
Akero Therapeutics
AKRO
-5,488
Closed -$261K
ALE
1573
DELISTED
Allete
ALE
-8,205
Closed -$545K
AMSC icon
1574
American Superconductor
AMSC
$1.6B
-3,379
Closed -$201K
AVDX
1575
DELISTED
AvidXchange
AVDX
-13,313
Closed -$132K

Similar funds

Xponance's Q4 2025 Portfolio in Review

As of Q4 2025, Xponance held 1,618 positions worth $13.3B, up 5.5% from $12.6B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Xponance deployed $449M of net new capital in Q4 2025, opening 92 new positions and adding to 926 existing holdings. Its largest new stake was Solstice Advanced Materials: 63,792 shares worth $3.1M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $6.88M trimmed.

  • Xponance's largest Q4 2025 buy was Solstice Advanced Materials: 63,792 shares worth $3.1M.
  • Xponance added most to Amazon in Q4 2025, an estimated $25.8M increase.
  • Xponance's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $6.88M.
  • Xponance fully exited Kellanova in Q4 2025, selling an estimated $3.29M.
  • Xponance's ten largest holdings make up 42% of its $13.3B portfolio in Q4 2025.
  • Xponance opened 92 new positions and closed 48 in Q4 2025.
  • Xponance's portfolio value rose 5.5% quarter-over-quarter to $13.3B.

Based on Xponance's 13F filing for Q4 2025, filed 12 Feb 2026.